Strategic Acquisition Bend Research is a division of Capsugel and sits within a larger dosage form solutions business, signaling potential for cross-selling of Capsugel’s comprehensive capsule technologies, formulation services, and support across biopharma and consumer health customers.

Integrated Capabilities Capsugel’s end-to-end expertise in science, engineering, formulation, capsule polymer science, and process design creates opportunities to upsell advanced dosage form solutions and rapid development programs to existing Bend Research clients seeking optimized bioavailability and targeted delivery.

Mid-market Focus With Bend Research’s estimated revenue in the $100M–$250M range and a mid-sized employee base, there is potential to align sales efforts toward midsize biopharma and contract development with needs for scalable, customized dosage forms.

Portfolio Alignment Potential to cross-sell proprietary and patent-protected technologies to clients needing novel delivery platforms, enabling clients to meet target product profiles and accelerate product timelines.

Growth Synergies Leverage Capsugel’s and Bend Research’s combined track record and global reach to target similar service providers and CDMOs in the ecosystem, expanding opportunities in dosage form solutions and niche formulation capabilities.